Author

Sarah Parackal

Hudson Institute of Medical ResearchORCID 0000-0003-4128-4073Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Abdul MannaniD· 1 shared Alicia M. DouglasiD· 1 shared Brett NixoniD· 1 shared Bryce C. ThomasiD· 1 shared Carl Johannes KoschmanniD· 1 shared Charles Edo de BockiD· 1 shared Christopher L. TinkleiD· 1 shared Christopher V. DayasiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdul MannanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyJournal of Clinical InvestigationPeer-reviewedFeb 6, 2024

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

Ryan J. Duchatel, Evangeline R. Jackson, Sarah Parackal…·Matthew D. Dun

This study identifies PI3K/mTOR as a targetable genetic dependency in DIPG and demonstrates that combining paxalisib with metformin improves survival in xenograft models.

53 citationstop 1%

mouseproteomics

𝕏 PostBluesky